Correlation Between Clean Science and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Clean Science and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clean Science and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clean Science co and AptaBio Therapeutics, you can compare the effects of market volatilities on Clean Science and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clean Science with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clean Science and AptaBio Therapeutics.
Diversification Opportunities for Clean Science and AptaBio Therapeutics
0.88 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Clean and AptaBio is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Clean Science co and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Clean Science is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clean Science co are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Clean Science i.e., Clean Science and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Clean Science and AptaBio Therapeutics
Assuming the 90 days trading horizon Clean Science co is expected to generate 0.82 times more return on investment than AptaBio Therapeutics. However, Clean Science co is 1.21 times less risky than AptaBio Therapeutics. It trades about 0.46 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about 0.31 per unit of risk. If you would invest 405,000 in Clean Science co on October 9, 2024 and sell it today you would earn a total of 92,000 from holding Clean Science co or generate 22.72% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Clean Science co vs. AptaBio Therapeutics
Performance |
Timeline |
Clean Science co |
AptaBio Therapeutics |
Clean Science and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Clean Science and AptaBio Therapeutics
The main advantage of trading using opposite Clean Science and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clean Science position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.Clean Science vs. Jeju Bank | Clean Science vs. CU Medical Systems | Clean Science vs. DoubleU Games Co | Clean Science vs. DB Financial Investment |
AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Stocks Directory Find actively traded stocks across global markets | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |